116 related articles for article (PubMed ID: 30863125)
21. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():453. PubMed ID: 25834381
[TBL] [Abstract][Full Text] [Related]
22. Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].
Neuropsychiatr Dis Treat; 2017; 13():2219. PubMed ID: 28860779
[TBL] [Abstract][Full Text] [Related]
23. Options and limitations of teicoplanin in febrile granulocytopenic patients.
De Pauw BE; Novakova IR; Donnelly JP
Br J Haematol; 1990 Dec; 76 Suppl 2():1-5. PubMed ID: 2149042
[TBL] [Abstract][Full Text] [Related]
24. Erratum: Association between patients' beliefs and oral antidiabetic medication adherence in a Chinese type 2 diabetic population [Corrigendum].
Patient Prefer Adherence; 2016; 10():1697. PubMed ID: 27660418
[TBL] [Abstract][Full Text] [Related]
25. Retrospective study of teicoplanin loading regimen that rapidly achieves target 15-30 μg/mL serum trough concentration.
Kato H; Hamada Y; Hagihara M; Hirai J; Nishiyama N; Koizumi Y; Yamagishi Y; Matsuura K; Mikamo H
J Infect Chemother; 2016 May; 22(5):308-13. PubMed ID: 26960579
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of teicoplanin concentrations and safety analysis in neonates.
Yamada T; Kubota T; Nakamura M; Ochiai M; Yonezawa M; Yano T; Kawashiri T; Egashira N; Hara T; Masuda S
Int J Antimicrob Agents; 2014 Nov; 44(5):458-62. PubMed ID: 25218156
[TBL] [Abstract][Full Text] [Related]
27. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
Greenberg RN
Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
[TBL] [Abstract][Full Text] [Related]
28. Single-centre retrospective observational study comparing trough blood concentration and safety of teicoplanin formulations.
Shinoda R; Shinoda Y; Ohashi K; Matsuoka T; Hirose T; Sugiyama T; Yoshimura T
J Infect Chemother; 2019 Jul; 25(7):563-566. PubMed ID: 30929977
[TBL] [Abstract][Full Text] [Related]
29. Optimal Trough Concentration of Teicoplanin in Febrile Neutropenic Patients with Hematological Malignancy.
Sato Y; Hiramatsu K; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Ogata M; Kadota JI; Itoh H
Chemotherapy; 2018; 63(1):29-34. PubMed ID: 29169153
[TBL] [Abstract][Full Text] [Related]
30. [Clinical study of teicoplanin in the treatment of patients with gram-positive cocci: the Chinese experience].
He LX; Pan J; Chen SY; Wang AX; Xie CM; Shen ZY
Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):337-41. PubMed ID: 16009001
[TBL] [Abstract][Full Text] [Related]
31. Erratum: Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum].
Onco Targets Ther; 2017; 10():1707. PubMed ID: 28356757
[TBL] [Abstract][Full Text] [Related]
32. Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features.
Seki M; Yabuno K; Miyawaki K; Miwa Y; Tomono K
Clin Pharmacol; 2012; 4():71-5. PubMed ID: 23236257
[TBL] [Abstract][Full Text] [Related]
33. Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
Clin Ophthalmol; 2017; 11():303. PubMed ID: 28223773
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
[TBL] [Abstract][Full Text] [Related]
35. Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics.
Niwa T; Imanishi Y; Ohmori T; Matsuura K; Murakami N; Itoh Y
Int J Antimicrob Agents; 2010 May; 35(5):507-10. PubMed ID: 20185275
[TBL] [Abstract][Full Text] [Related]
36. Measurement of Teicoplanin Concentration With Liquid Chromatography-Tandem Mass Spectrometry Method Demonstrates the Usefulness of Therapeutic Drug Monitoring in Hematologic Patient Populations.
Chae H; Lee JJ; Cha K; Her SH; Kim HY; Han E; Kim M; Kim Y; Cho SY; Lee DG
Ther Drug Monit; 2018 Jun; 40(3):330-336. PubMed ID: 29746433
[TBL] [Abstract][Full Text] [Related]
37. Erratum: Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2016; 11():1031-1033. PubMed ID: 27274224
[TBL] [Abstract][Full Text] [Related]
38. Erratum: Intrathecal baclofen pump infection treated by adjunct intrareservoir teicoplanin instillation.
Surg Neurol Int; 2017; 8():119. PubMed ID: 28680738
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
Kempf P; Pompetzki H; Oppermann A; Wittenberger R; Siebert J; Fell JJ; Dieterich HA
Infection; 1989; 17(3):177-81. PubMed ID: 2525529
[TBL] [Abstract][Full Text] [Related]
40. Erratum: corrigendum.
Clin Ophthalmol; 2011; 5():1557. PubMed ID: 22125401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
